 | • レポートコード：MRC2012B0109 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、軸性脊椎関節炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。軸性脊椎関節炎治療の種類別市場規模（医学的治療、理学療法治療）、用途別市場規模（病院、リハビリテーションセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：UCB Biosciences、Merck Sharp & Dohme、Pfizer、Abbott Pharmaceuticals、GlaxoSmithKline、 ・地域別グローバル市場分析 2015年-2020年 ・軸性脊椎関節炎治療の北米市場（アメリカ、カナダ、メキシコ） ・軸性脊椎関節炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・軸性脊椎関節炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・軸性脊椎関節炎治療の南米市場（ブラジル、アルゼンチン） ・軸性脊椎関節炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：医学的治療、理学療法治療 ・用途別分析：病院、リハビリテーションセンター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Axial Spondyloarthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Axial Spondyloarthritis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Axial Spondyloarthritis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Axial Spondyloarthritis Treatment market has been segmented into:
Medical Treatement
Physiotherapy Treatement
By Application, Axial Spondyloarthritis Treatment has been segmented into:
Hospital
Rehabilitation Center
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Axial Spondyloarthritis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Axial Spondyloarthritis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Axial Spondyloarthritis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Axial Spondyloarthritis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Axial Spondyloarthritis Treatment Market Share Analysis
Axial Spondyloarthritis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Axial Spondyloarthritis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Axial Spondyloarthritis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Axial Spondyloarthritis Treatment are:
UCB Biosciences
Merck Sharp & Dohme
Pfizer
Abbott Pharmaceuticals
GlaxoSmithKline
Among other players domestic and global, Axial Spondyloarthritis Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Axial Spondyloarthritis Treatment Market Overview
1.1 Product Overview and Scope of Axial Spondyloarthritis Treatment
1.2 Classification of Axial Spondyloarthritis Treatment by Type
1.2.1 Global Axial Spondyloarthritis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Axial Spondyloarthritis Treatment Revenue Market Share by Type in 2019
1.2.3 Medical Treatement
1.2.4 Physiotherapy Treatement
1.3 Global Axial Spondyloarthritis Treatment Market by Application
1.3.1 Overview: Global Axial Spondyloarthritis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Rehabilitation Center
1.3.4 Other
1.4 Global Axial Spondyloarthritis Treatment Market by Regions
1.4.1 Global Axial Spondyloarthritis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Axial Spondyloarthritis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Axial Spondyloarthritis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Axial Spondyloarthritis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Axial Spondyloarthritis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Axial Spondyloarthritis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Axial Spondyloarthritis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 UCB Biosciences
2.1.1 UCB Biosciences Details
2.1.2 UCB Biosciences Major Business
2.1.3 UCB Biosciences SWOT Analysis
2.1.4 UCB Biosciences Product and Services
2.1.5 UCB Biosciences Axial Spondyloarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck Sharp & Dohme
2.2.1 Merck Sharp & Dohme Details
2.2.2 Merck Sharp & Dohme Major Business
2.2.3 Merck Sharp & Dohme SWOT Analysis
2.2.4 Merck Sharp & Dohme Product and Services
2.2.5 Merck Sharp & Dohme Axial Spondyloarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Axial Spondyloarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Pharmaceuticals
2.4.1 Abbott Pharmaceuticals Details
2.4.2 Abbott Pharmaceuticals Major Business
2.4.3 Abbott Pharmaceuticals SWOT Analysis
2.4.4 Abbott Pharmaceuticals Product and Services
2.4.5 Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Axial Spondyloarthritis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Axial Spondyloarthritis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Axial Spondyloarthritis Treatment Players Market Share
3.2.2 Top 10 Axial Spondyloarthritis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Axial Spondyloarthritis Treatment Revenue and Market Share by Regions
4.2 North America Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
5 North America Axial Spondyloarthritis Treatment Revenue by Countries
5.1 North America Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
5.2 USA Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Axial Spondyloarthritis Treatment Revenue by Countries
6.1 Europe Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
6.2 Germany Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Axial Spondyloarthritis Treatment Revenue by Countries
7.1 Asia-Pacific Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
7.2 China Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
8 South America Axial Spondyloarthritis Treatment Revenue by Countries
8.1 South America Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Axial Spondyloarthritis Treatment by Countries
9.1 Middle East & Africa Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Axial Spondyloarthritis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Axial Spondyloarthritis Treatment Market Forecast by Type (2019-2024)
10.3 Medical Treatement Revenue Growth Rate (2015-2025)
10.4 Physiotherapy Treatement Revenue Growth Rate (2015-2025)
11 Global Axial Spondyloarthritis Treatment Market Segment by Application
11.1 Global Axial Spondyloarthritis Treatment Revenue Market Share by Application (2015-2020)
11.2 Axial Spondyloarthritis Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Rehabilitation Center Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Axial Spondyloarthritis Treatment Market Size Forecast (2021-2025)
12.1 Global Axial Spondyloarthritis Treatment Market Size Forecast (2021-2025)
12.2 Global Axial Spondyloarthritis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Axial Spondyloarthritis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Axial Spondyloarthritis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Axial Spondyloarthritis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Axial Spondyloarthritis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Axial Spondyloarthritis Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. UCB Biosciences Corporate Information, Location and Competitors
Table 7. UCB Biosciences Axial Spondyloarthritis Treatment Major Business
Table 8. UCB Biosciences Axial Spondyloarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 9. UCB Biosciences SWOT Analysis
Table 10. UCB Biosciences Axial Spondyloarthritis Treatment Product and Solutions
Table 11. UCB Biosciences Axial Spondyloarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Merck Sharp & Dohme Corporate Information, Location and Competitors
Table 13. Merck Sharp & Dohme Axial Spondyloarthritis Treatment Major Business
Table 14. Merck Sharp & Dohme Axial Spondyloarthritis Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Merck Sharp & Dohme SWOT Analysis
Table 16. Merck Sharp & Dohme Axial Spondyloarthritis Treatment Product and Solutions
Table 17. Merck Sharp & Dohme Axial Spondyloarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Pfizer Corporate Information, Location and Competitors
Table 19. Pfizer Axial Spondyloarthritis Treatment Major Business
Table 20. Pfizer Axial Spondyloarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Pfizer SWOT Analysis
Table 22. Pfizer Axial Spondyloarthritis Treatment Product and Solutions
Table 23. Pfizer Axial Spondyloarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Abbott Pharmaceuticals Corporate Information, Location and Competitors
Table 25. Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Major Business
Table 26. Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Abbott Pharmaceuticals SWOT Analysis
Table 28. Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Product and Solutions
Table 29. Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. GlaxoSmithKline Corporate Information, Location and Competitors
Table 31. GlaxoSmithKline Axial Spondyloarthritis Treatment Major Business
Table 32. GlaxoSmithKline Axial Spondyloarthritis Treatment Total Revenue (USD Million) (2017-2018)
Table 33. GlaxoSmithKline SWOT Analysis
Table 34. GlaxoSmithKline Axial Spondyloarthritis Treatment Product and Solutions
Table 35. GlaxoSmithKline Axial Spondyloarthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global Axial Spondyloarthritis Treatment Revenue (Million USD) by Players (2015-2020)
Table 37. Global Axial Spondyloarthritis Treatment Revenue Share by Players (2015-2020)
Table 38. Global Axial Spondyloarthritis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 39. Global Axial Spondyloarthritis Treatment Revenue Market Share by Regions (2015-2020)
Table 40. North America Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
Table 41. North America Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 42. Europe Axial Spondyloarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific Axial Spondyloarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 44. South America Axial Spondyloarthritis Treatment Revenue by Countries (2015-2020)
Table 45. South America Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa Axial Spondyloarthritis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Global Axial Spondyloarthritis Treatment Revenue (Million USD) by Type (2015-2020)
Table 49. Global Axial Spondyloarthritis Treatment Revenue Share by Type (2015-2020)
Table 50. Global Axial Spondyloarthritis Treatment Revenue Forecast by Type (2021-2025)
Table 51. Global Axial Spondyloarthritis Treatment Revenue by Application (2015-2020)
Table 52. Global Axial Spondyloarthritis Treatment Revenue Share by Application (2015-2020)
Table 53. Global Axial Spondyloarthritis Treatment Revenue Forecast by Application (2021-2025)
Table 54. Global Axial Spondyloarthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Axial Spondyloarthritis Treatment Picture
Figure 2. Global Axial Spondyloarthritis Treatment Revenue Market Share by Type in 2019
Figure 3. Medical Treatement Picture
Figure 4. Physiotherapy Treatement Picture
Figure 5. Axial Spondyloarthritis Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Rehabilitation Center Picture
Figure 8. Other Picture
Figure 9. Global Axial Spondyloarthritis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Axial Spondyloarthritis Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Axial Spondyloarthritis Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Axial Spondyloarthritis Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Axial Spondyloarthritis Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Axial Spondyloarthritis Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Axial Spondyloarthritis Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Axial Spondyloarthritis Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Axial Spondyloarthritis Treatment Revenue Market Share by Countries in 2019
Figure 42. China Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Axial Spondyloarthritis Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Axial Spondyloarthritis Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Axial Spondyloarthritis Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Axial Spondyloarthritis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Axial Spondyloarthritis Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Axial Spondyloarthritis Treatment Revenue Share by Type in 2019
Figure 59. Global Axial Spondyloarthritis Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Medical Treatement Revenue Growth Rate (2015-2020)
Figure 61. Global Physiotherapy Treatement Revenue Growth Rate (2015-2020)
Figure 62. Global Axial Spondyloarthritis Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Axial Spondyloarthritis Treatment Revenue Share by Application in 2019
Figure 64. Global Axial Spondyloarthritis Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Rehabilitation Center Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Axial Spondyloarthritis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Axial Spondyloarthritis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Axial Spondyloarthritis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Axial Spondyloarthritis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
体軸性脊椎関節炎薬の世界市場（～2026年） Market Analysis and Insights: Global Axial Spondyloarthritis Drugs Market The global Axial Spondyloarthritis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Axial Spondyloarthritis Drugs Scope and Market Size Axi…- 軸方向/ねじり試験システムの世界市場（～2026年） Combined axial and torsional loading, or biaxial tests are common to metals testing, biomechanics, tissue engineering, orthopedics and composites testing applications. Market Analysis and Insights: Global Axial / Torsional Test Systems Market The global Axial / Torsional Test Systems market size is …
- 聴神経鞘腫治療の世界市場（～2026年） Market Analysis and Insights: Global Acoustic Neurinoma Treatment Market The global Acoustic Neurinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acoustic Neurinoma Treatment Scope and Market Size Acoust…
- ディンプルプラスティ治療の世界市場（～2026年） Dimpleplasty, is a minimally invasive procedure used to create dimples in the face, most commonly within the cheeks. Dimple surgery is performed with incisions in the mouth behind the area in the cheek where the dimples are created. A temporary self-absorbing suture is used to create the dimple with…
- 腹水治療の世界市場（～2026年） Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. North America and Europe together account for largest market share in the overall ascites treatment market. Highly deve…